Understanding Autosomal Dominant Ichthyosis Vulgaris: The Role of Genetic Testing

Medically reviewed by Brandon Colby, MD, last reviewed Oct 21, 2026

Short answer: Ichthyosis vulgaris is a common inherited skin condition that causes dry, scaly skin and affects about 1 in 250 people. It is caused by variants in the FLG gene, which makes filaggrin, a protein that helps skin hold moisture. In the autosomal dominant form, one changed copy is enough, so a parent has a 50% chance of passing it on.

Autosomal Dominant Ichthyosis Vulgaris (ADIV) is a common genetic skin disorder characterized by dry, scaly skin. Affecting approximately 1 in 250 individuals, this condition often manifests in childhood and can vary in severity. While it may not be life-threatening, its impact on quality of life can be significant. This article explores how genetic testing can play a pivotal role in diagnosing and managing ADIV.

What is Autosomal Dominant Ichthyosis Vulgaris?

Ichthyosis vulgaris is a type of skin disorder where the skin fails to shed dead skin cells, leading to a build-up of scales. In the autosomal dominant form, a single copy of the altered gene in each cell is sufficient to cause the disorder. The condition is often inherited from an affected parent, making genetic testing an essential tool for understanding and managing the disease.

The Science Behind Genetic Testing

Genetic testing involves examining an individual's DNA to identify changes or variants in genes that may cause a disease. For ADIV, this means looking for variants in the FLG gene, which is responsible for producing filaggrin, a protein crucial for skin barrier function. A variant in this gene disrupts the skin's ability to retain moisture, leading to the characteristic dryness and scaling of ichthyosis vulgaris.

Diagnosing Autosomal Dominant Ichthyosis Vulgaris

Genetic testing can confirm a diagnosis of ADIV by identifying variants in the FLG gene. This is particularly useful in cases where clinical symptoms are ambiguous or overlap with other skin conditions. A definitive genetic diagnosis can guide treatment decisions and provide clarity to affected individuals and their families.

Predicting Disease Severity and Progression

While genetic testing can confirm the presence of ADIV, it can also provide insights into the potential severity and progression of the disease. Certain variants in the FLG gene are associated with more severe symptoms, and understanding these genetic markers can help clinicians tailor management strategies to the individual’s specific needs.

Informing Family Planning Decisions

For individuals with ADIV, genetic testing can offer valuable information for family planning. Since the condition is autosomal dominant, there is a 50% chance of passing the mutated gene to offspring. Genetic counseling, informed by test results, can help prospective parents understand the risks and make informed reproductive choices.

Advancing Research and Treatment Options

Beyond individual diagnosis and management, genetic testing contributes to broader research efforts aimed at understanding ichthyosis vulgaris and developing new treatments. By identifying specific genetic variants, researchers can explore targeted therapies that address the underlying genetic causes of the disorder, potentially leading to more effective treatments in the future.

Conclusion: The Future of Genetic Testing in ADIV

As genetic testing becomes more accessible and affordable, its role in diagnosing and managing autosomal dominant ichthyosis vulgaris is likely to expand. For patients and families affected by this condition, genetic insights offer hope for more personalized care and improved quality of life. Moreover, ongoing research fueled by genetic data holds promise for new therapeutic approaches that could transform the management of ichthyosis vulgaris.

For more detail on the genetics of this condition, see the NCBI MedGen entry: Autosomal dominant ichthyosis vulgaris (NCBI MedGen).

Get Tested With Whole Genome Sequencing

Whole genome sequencing reads 100% of your DNA, including over 30,000 genes such as FLG. Every Sequencing Kit Bundle includes Next Gen Disease Screening, which analyzes your genome for more than 15,000 conditions, and the Professional Health Screen Bundle includes a Skin health area. A genetic result is not a diagnosis, so talk with a dermatologist or genetic counselor before acting on it.

Shop All Whole Genome Sequencing Kit Bundles

Frequently Asked Questions

What is ichthyosis vulgaris?

Ichthyosis vulgaris is a common inherited skin condition in which the skin does not shed dead cells normally, so dry, scaly patches build up. It often starts in childhood, ranges from mild to more noticeable and affects about 1 in 250 people.

Which gene causes ichthyosis vulgaris?

Variants in the FLG gene cause it. FLG makes filaggrin, a protein the skin needs to hold in moisture, so a variant leads to dry, scaly skin.

Is ichthyosis vulgaris inherited?

Yes. In the autosomal dominant form one changed copy of the gene is enough, so a parent who has it has a 50% chance of passing it to each child.

Does genetic testing change treatment?

A dermatologist usually diagnoses ichthyosis vulgaris from the skin. Genetic testing can confirm it when symptoms overlap with other skin conditions, and treatment focuses on moisturizing and removing scale under medical guidance.

Sources and Patient Organizations

This page is for education and is not medical advice. Genetic results show risk and do not diagnose a condition. Talk with a clinician or genetic counselor about your results.

Atopic Dermatitis Susceptibility: eczema and the FLG skin barrier gene.
IgE Responsiveness in Atopic Disease: allergy related genes that overlap with FLG.